← Leaderboards
Seiichi Yamano
New York University
$2,303,234
Attributed
$4,606,468
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $583.8K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,606,468 · 3
By mechanism
R01$4,210,218 · 2
R56$396,250 · 1
Top collaborators
- Brian L Schmidt10 shared
Most similar at New York University
Same institution · by research overlap
- Brian L Schmidt$17,732,867
- Nigel W Bunnett$19,331,815
- Paulina Daniela Ramirez Garcia$271,403
- Alex Rojas Bie Thomsen$2,340,998
- Yatendra Mulpuri$162,743
Others in their field
Top investigators on “Opioid”
- Chanza Baytop · Westat, Inc.$271,217,917
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Sharon L. Walsh · University Of Kentucky$96,444,120
- Jeffrey H Samet · Boston University Medical Campus$95,014,310
- Edward V Nunes · Columbia University Health Sciences$85,118,880
Research focus
OpioidNormal Tissue MorphologyNon-Viral VectorLipidsNon-Viral Gene TherapyNociceptionClinical TrialsMalignant Mouth NeoplasmGene TherapyIn VivoMouse ModelAttenuatedAttenuationCytotoxicityChemical CarcinogenCancer CellEatingFunctional RestorationGenesCancer PainCancer PatientInnovationMalignant NeoplasmsOral
Grant awards (10)
Intratumor co-delivery of DNA and RNA to relieve cancer pain$583,847
R01 · FY2025 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain$567,884
R01 · FY2024 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain$583,847
R01 · FY2023 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain$573,679
R01 · FY2022 · DE
Intratumor co-delivery of DNA and RNA to relieve cancer pain$583,847
R01 · FY2021 · DE
Non-viral gene therapy for cancer pain$397,065
R01 · FY2018 · DE
Non-viral gene therapy for cancer pain$401,629
R01 · FY2017 · DE
Non-viral gene therapy for cancer pain$111,367
R01 · FY2017 · DE
Non-viral gene therapy for cancer pain$407,053
R01 · FY2016 · DE
Non-viral gene therapy for cancer pain.$396,250
R56 · FY2015 · DE